Argus Research Maintains Buy on Boston Scientific, Raises Price Target to $80
Portfolio Pulse from Benzinga Newsdesk
Argus Research analyst John Eade maintains a Buy rating on Boston Scientific (NYSE:BSX) and raises the price target from $69 to $80.
April 03, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Argus Research maintains a Buy rating on Boston Scientific and increases the price target to $80.
The upgrade in the price target by Argus Research indicates a positive outlook on Boston Scientific's stock, suggesting potential upside. This is likely to instill confidence among investors, potentially driving the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100